Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Chest clinic

Case based discussion

Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage

Online download statistics by month:

Online download statistics by month: October 2019 to April 2022

	Abstract	Full	Pdf
Oct 2019	184	8	1
Nov 2019	678	82	54
Dec 2019	1040	61	41
Jan 2020	909	64	30
Feb 2020	171	30	13
Mar 2020	182	28	21
Apr 2020	102	14	5
May 2020	111	14	8
Jun 2020	113	15	7
Jul 2020	153	11	5
Aug 2020	92	17	8
Sep 2020	98	10	5
Oct 2020	92	11	10
Nov 2020	89	24	19
Dec 2020	114	8	4
Jan 2021	59	11	8
Feb 2021	111	9	5
Mar 2021	85	12	6
Apr 2021	57	10	6
May 2021	28	13	7
Jun 2021	17	14	9
Jul 2021	7	5	3
Aug 2021	7	3	1
Sep 2021	16	8	5
Oct 2021	74	17	7
Nov 2021	85	9	4
Dec 2021	88	7	5
Jan 2022	106	4	1
Feb 2022	40	2	2
Mar 2022	96	9	4
Apr 2022	93	4	5
Total	5097	534	309